- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07618819
AI-Assisted Structured Guidance for Narrative Review Writing
Effect of Artificial Intelligence-Assisted Structured Guidance on the Quality of Narrative Literature Reviews Among Medical Postgraduate Students: A Randomized Controlled Educational Study
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Generative artificial intelligence is increasingly used by medical students and postgraduate trainees for literature searching, summarization, outlining, and academic writing. However, free use of AI may be associated with inaccurate information, unsupported statements, fabricated references, and inadequate academic judgment. This study is designed to evaluate whether structured guidance can improve the quality and academic integrity of AI-assisted narrative review writing.
Participants will be medical postgraduate students enrolled in an academic writing course. After informed consent and baseline data collection, participants will be randomized in a 1:1 ratio to an AI-assisted structured guidance group or a free AI use group. Both groups will complete a narrative literature review of approximately 2,000 Chinese characters according to the same course requirements and may use AI tools under academic integrity requirements.
Participants in the AI-assisted structured guidance group will receive one structured guidance session approximately two weeks before final submission. The session will be based on the six SANRA dimensions: explanation of the importance of the article, statement of aims or questions, description of the literature search, reference support for key statements, scientific reasoning, and appropriate presentation of data and content. The instructor will provide directional and methodological feedback but will not directly write or edit the students' text line by line. Participants in the free AI use group will complete the review according to the same course requirements without the structured guidance session.
After submission, all narrative reviews will be anonymized and assessed by independent outcome assessors blinded to group allocation. The primary outcome is the final SANRA total score. Secondary outcomes include SANRA item scores, multiple-source academic writing self-efficacy, and reference authenticity error rate.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Guangming Jin
- Telefonnummer: +86-13560035613
- E-Mail: jinguangming@gzzoc.com
Studienorte
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Master's students enrolled in the Academic Standards and Thesis Writing course.
- Willing to participate in this study, able to understand the study procedures and randomization arrangement, and able to provide written informed consent.
- Able to complete literature searching, use AI tools, and complete online questionnaires.
Exclusion Criteria:
- Students who have confirmed withdrawal from the course, suspension of study, long-term leave, or other known objective reasons that prevent participation in subsequent major teaching activities and study procedures.
- Students who have participated in pilot testing, intervention material development, assessment training, or data processing related to this study.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: AI-Assisted Structured Guidance Group
Participants in this group will complete a narrative literature review according to the same course requirements as the control group.
They may use AI tools under academic integrity requirements and will additionally receive one structured guidance session approximately two weeks before final submission.
|
A single structured guidance session delivered approximately two weeks before final submission.
The session is based on the six SANRA dimensions and provides directional and methodological feedback on narrative review writing and appropriate AI use, without direct writing or line-by-line editing of students' text.
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
|
Aktiver Komparator: Free AI Use Group
Participants in this group will complete a narrative literature review according to the same course requirements and may use AI tools under academic integrity requirements.
They will not receive the structured guidance session during the study period.
|
Participants may use AI tools freely under academic integrity requirements while completing the narrative literature review.
Students are responsible for verifying AI-generated content, medical facts, and reference authenticity.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Final SANRA Total Score
Zeitfenster: Week 2
|
The quality of the final narrative literature review will be assessed using the Scale for the Assessment of Narrative Review Articles (SANRA).
The SANRA total score ranges from 0 to 12, with higher scores indicating better quality of the narrative review.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
SANRA Item 1 Score: Importance of the Article
Zeitfenster: Week 2
|
This outcome assesses SANRA item 1, which evaluates whether the importance of the narrative review article is adequately explained.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 2 Score: Aims or Questions
Zeitfenster: Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 3 Score: Literature Search Description
Zeitfenster: Week 2
|
This outcome assesses SANRA item 3, which evaluates whether the literature search process is described.
The item score ranges from 0 to 2, with higher scores indicating better reporting.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 4 Score: Referencing
Zeitfenster: Week 2
|
At final submission of the narrative literature review; assessment completed within 4 weeks after final submission.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 5 Score: Scientific Reasoning
Zeitfenster: Week 2
|
This outcome assesses SANRA item 5, which evaluates whether the scientific reasoning is based on appropriate evidence.
The item score ranges from 0 to 2, with higher scores indicating better scientific reasoning.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
SANRA Item 6 Score: Data and Content Presentation
Zeitfenster: Week 2
|
This outcome assesses SANRA item 6, which evaluates whether data and content are presented appropriately.
The item score ranges from 0 to 2, with higher scores indicating better presentation.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
|
Change From Baseline in Multiple-Source Academic Writing Self-Efficacy Score
Zeitfenster: Baseline and Week 2
|
Multiple-source academic writing self-efficacy will be assessed using an adapted 8-item Multiple-Source Academic Writing Self-Efficacy Scale.
The change from baseline to final submission will be analyzed.
Higher scores indicate greater self-efficacy in integrating multiple sources for academic writing.
|
Baseline and Week 2
|
|
Reference Authenticity Error Rate
Zeitfenster: Week 2
|
The proportion of references with authenticity errors will be calculated for each submitted narrative literature review.
References will be verified using available bibliographic information such as DOI, PMID, title, authors, PubMed, CrossRef, Web of Science, Google Scholar, journal websites, or publisher websites.
A higher error rate indicates poorer reference authenticity.The outcome will be assessed based on the narrative literature review submitted at Week 2.
|
Week 2
|
Mitarbeiter und Ermittler
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- IIT2026064
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .